Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01885897 | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT | ||
| NCT00619021 | Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | ||
| NCT05025774 | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise | ||
| NCT00643240 | Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT00167180 | Post Transplant Donor Lymphocyte Infusion | ||
| NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | ||
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | ||
| NCT04530695 | Diagnosis and Treatment of Periodontal Disease in Patients With AML | ||
| NCT06412497 | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. | ||
| NCT04426669 | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | ||
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT03642626 | MT2017-45: CAR-T Cell Therapy for Heme Malignancies | ||
| NCT00346125 | PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma | ||
| NCT00290641 | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT00455312 | Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA | ||
| NCT01158456 | Metabolism of NNK Among African Americans | ||
| NCT00381888 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT02948062 | Early Diagnosis Of Childhood Cerebral ALD | ||
| NCT02046291 | Safety of Romiplostim (Nplate®) Following UCBT | ||
| NCT05708703 | Assessing the Time Demands of Cancer | ||
| NCT02179359 | Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies | ||
| NCT00725062 | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | ||
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT00287911 | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT06442384 | Remote Trial - Tobacco Product Standard (VLNC) | ||
| NCT00303719 | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | ||
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT03417154 | Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS | ||
| NCT00609739 | Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | ||
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT04225572 | Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) | ||
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT00319748 | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | ||
| NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT00005984 | Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia | ||
| NCT00005985 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | ||
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | ||
| NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT06544811 | American Indian Smokefree Native RCT |
